High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD
HIIT_PAD
Short-duration Aerobic High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Symptomatic Patients With Peripheral Artery Disease: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Supervised exercise training (SET) is considered among first-line therapies for patients with symptomatic lower extremity peripheral artery disease (PAD), combined with general cardiovascular risk management, lifestyle adaptation and pharmacological treatment. Although without clear consistency, the guidelines give recommendations in terms of claudication pain severity, SET volume, duration, and frequency. However, no or little guidance is offered as far as training intensity is concerned. Most of the previous studies on SET, in the context of PAD, did not distinguish between symptom intensity and common training intensity measures such as % of maximal heart rate (%HRmax), % of HR reserve (%HRR), % of peak oxygen uptake (%VO2peak), % of VO2 reserve (%VO2R), or the rate of perceived exertion (RPE). In a recent meta-analysis, we demonstrated that both training modality and exercise intensity (based on %peak heart rate, %peak oxygen uptake, or the rate of perceived exertion) should be considered when looking for the best results in patients with symptomatic PAD. These results call for study of the individual roles of each exercise intensity and modality on walking performance and cardiorespiratory fitness in patients with symptomatic PAD. High-intensity interval training (HIIT) is composed of brief bursts of vigorous intensity interspersed with periods of rest or low-intensity exercise. HIIT may be better than moderate-intensity training (MIT) in improving cardiorespiratory fitness and functional capacity in patients with cardiovascular and metabolic diseases, but in patients with symptomatic PAD, the effects of such modalities on walking ability and cardiorespiratory fitness remain to be clearly determined. The primary objective of this study is to compare the effects of 12-week-long exercise training (short-duration high-intensity intervals vs. low-to-moderate intensity) on treadmill performance in patients with symptomatic PAD. It is hypothesized that treadmill performance would be improved to a greater extent after high-intensity exercise training
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
November 10, 2022
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedMarch 15, 2024
March 1, 2024
4 months
October 31, 2022
March 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximal walking distance
Patients will perform an incremental treadmill test to determine the maximal walking distance (MWD). Initial walking speed will be set at 3.2 km/h, and at 0% grade. The grade will be increased by 2% each 2 min.
This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.
Secondary Outcomes (12)
Functional performance - 6-minute walk test
This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.
Functional performance - ascending and descending stair performance test
This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.
Functional performance - short physical performance battery test
This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.
Functional performance - preferred walking speed and gait analysis assessment
This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.
Functional performance - unipedal stance test
This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.
- +7 more secondary outcomes
Study Arms (2)
High-intensity interval training group (HIIT)
EXPERIMENTALExercise training sessions will consist in an alternation of brief periods (≤ 60 s) of work performed at high intensity and brief period of passive rest. Patient will be asked to complete 1 set of 10-15x60-s (or 2 sets of 5-7x60-s) walking intervals. This protocol will elicits moderate-to-severe claudication pain during exertion. The training intensity in the HIIT group will be set at ≥85% HRpeak recorded during the maximal cardiopulmonary exercise test.
Low-to-moderate intensity training group (LowMod group)
EXPERIMENTALExercise training sessions will consist in an alternation of periods of work performed at moderate exercise intensity and period of passive rest. The training approach of the LowMod group will be similar to the training prescription usually adopted in patients with claudication. The exercise training intensity will be set at ≤76% HRpeak recorded during the maximal cardiopulmonary exercise test.
Interventions
Exercise training sessions will consist in an alternation of brief periods (≤ 60 s) of work performed at high intensity and brief period of passive rest. Patient will be asked to complete 1 set of 10-15x60-s (or 2 sets of 5-7x60-s) walking intervals. The training intensity in the HIIT group will be set at ≥85% HRpeak recorded during the maximal cardiopulmonary exercise test. The training intervention will consist of 36 walking sessions spread over 12 weeks. Each training session will lasted 30-60 min. The training intervention will be performed on a treadmill (Cosmed T150, Itlay), which is equipped with harness and chest belt to secure the patients and prevents falling. Each session started with a 5-min walking warm-up and ended with a 5min cool-down. During all the exercise training sessions, HR of the subjects will be continuously monitored (Polar M430, Finland).
Exercise training sessions will consist in an alternation of periods of work performed at moderate exercise intensity and period of passive rest. The training approach of the LowMod group will be similar to the training prescription usually adopted in patients with claudication. The exercise training intensity will be set at ≤76% HRpeak recorded during the maximal cardiopulmonary exercise test. The training intervention will consist of 36 walking sessions spread over 12 weeks. Each training session will lasted 30-60 min. The training intervention will be performed on a treadmill (Cosmed T150, Itlay), which is equipped with harness and chest belt to secure the patients and prevents falling. Each session started with a 5-min walking warm-up and ended with a 5min cool-down. During all the exercise training sessions, HR of the subjects will be continuously monitored (Polar M430, Finland).
Eligibility Criteria
You may qualify if:
- Adult patients with symptomatic PAD (Fontaine stage IIa/b);
- ABI ≤ 0.9 or drop by 20% following exercise treadmill test 1;
- TBI ≤ 0.6 if incompressible arteries (diabetes and renal insufficiency);
- Signed written informed consent form.
You may not qualify if:
- Age \< 18;
- Unable to walk at 3.2 km/h on a treadmill (slope 0%) at least 300 m;
- Previous participate in SET programs ≤ 1 year;
- Prior leg/foot amputation;
- Contraindication to exercise
- Neurological and neuromuscular disorders and other comorbidities (orthopedic, rheumatologic) leading to gait abnormalities.
- Known Pregnancy
- Incapacity of discernment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
Related Publications (1)
Lanzi S, Pousaz A, Fresa M, Besson C, Desgraz B, Gremeaux-Bader V, Mazzolai L. Short-duration aerobic high-intensity intervals versus moderate exercise training intensity in patients with peripheral artery disease: study protocol for a randomised controlled trial (the Angiof-HIIT Study). BMJ Open. 2024 Apr 17;14(4):e081883. doi: 10.1136/bmjopen-2023-081883.
PMID: 38631833DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof, MD, PhD
Study Record Dates
First Submitted
October 31, 2022
First Posted
November 10, 2022
Study Start
March 1, 2023
Primary Completion
July 1, 2023
Study Completion (Estimated)
January 1, 2028
Last Updated
March 15, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.